Mhd Baraa Habib

Mhd Baraa Habib

Auto-generated profile, based on publicly available information

Mhd Baraa Habib

Department of Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in IDCases
Verified
Journal Article
Open access
MHMhd Baraa Habib
Mhd Baraa Habib
THTahseen Hamamyh
Tahseen Hamamyh
AEAhmed Elyas
Ahmed Elyas
MAMohammed Altermanini
Mohammed Altermanini
MEMawahib Elhassan
Mawahib Elhassan
• To highlight acute myocarditis as a potential adverse complication of BNT162b2 vaccine. • To illustrate the clinical approach and investigations of myocarditis secondary to BNT162b2 vaccine. • Conservative management might be reasonable in mild cases.

6 August 2021 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
MHMhd Baraa Habib
Mhd Baraa Habib
MEMohamed Elshafei
Mohamed Elshafei
ARAlaa Rahhal
Alaa Rahhal
MMMouhand Mohamed
Mouhand Mohamed
The antiviral medication “favipiravir” should be considered as a possible cause of unexplained sinus bradycardia.

1 January 2021 in IDCases
Verified
Journal Article
Open access
SSSundus Sardar
Sundus Sardar
MAMohammed Abdurabu
Mohammed Abdurabu
AAAhmed Abdelhadi
Ahmed Abdelhadi
MHMhd Baraa Habib
Mhd Baraa Habib
MJMuhammad Jamshaid
Muhammad Jamshaid
KFKhalid Farooqui
Khalid Farooqui
Malaria infection, which results due to the parasitic protozoan Plasmodium, has several known etiologies of hemolytic anemia as a possible complication in cases such as concurrent G6PD deficiency, severe parasitemia, or use of parenteral antimalarials. Although artemisinin-based antimalarial therapies are generally well-tolerated, several cases of severe post-artemisinin delayed hemolysis (PADH) have been recently reported, which present a diagnostic challenge, and affect morbidity and mortality in patients with malarial infection. We highlight the case of a young lady with Plasmodium falciparum severe parasitemia who developed hemolytic anemia after parenteral artesunate therapy.

4 January 2021 in Cureus
Verified
Journal Article
Open access
PDF file
MHMhd Baraa Habib
Mhd Baraa Habib
IHIbrahem Hanafi
Ibrahem Hanafi
MAMaya Alzoubi
Maya Alzoubi
ZBZeina Bdeir
Zeina Bdeir
MYMohamed Yassin
Mohamed Yassin
Capecitabine (CAP) is an antineoplastic agent that is known to cause mild hepatotoxicity. However, severe and late acute liver injury was not reported previously as an adverse reaction of CAP. This report discusses the case of a 63-year-old man with colon cancer who was receiving the fifth cycle of CAP as a monotherapy and presented with fatigue and jaundice during the fifth cycle of CAP. Laboratory tests showed markedly elevated transaminases (aspartate transaminase: 2,448 U/L; alanine transaminase: 1,984 U/L). Eventually, discontinuation of CAP was enough to reverse the delayed CAP-induced acute hepatic injury in clinical and laboratory terms.

6 December 2021 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
EAElrazi Ali
Elrazi Ali
QAQusai Al-Maharmeh
Qusai Al-Maharmeh
WRWaail Mohammed Rozi
Waail Mohammed Rozi
MHMhd Baraa Habib
Mhd Baraa Habib
AAAhmed Abdallah
Ahmed Abdallah
MYMohamed Yassin
Mohamed Yassin
Introduction and importance Coronavirus disease 2019 (COVID-19) is a recently discovered disease that has yet to be thoroughly described. It is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel virus that can be transmitted easily from human to human, mainly by the respiratory route. The disease often presents with non-specific symptoms such as fever, headache, and fatigue, accompanied by respiratory symptoms (e.g., cough and dyspnea) and other systemic involvement. Currently, vaccination is the primary strategy to prevent transmission and reduce disease severity. However, vaccines have side effects, and the consequences of vaccination in different diseases are not well established. Moreover, the impact of SARS-CoV-2 vaccination during pregnancy is another not well-known area. Case presentation: We present a young lady known to have ITP, which was controlled for years, presented with relapse after taking the SARS-CoV-2 vaccine during pregnancy. Clinical discussion The patient had a relapse of ITP after the introduction of the first dose of the COVID-19 vaccine, which worsened further after the second dose. This suggests that patients with ITP who develop flare post-SARS-CoV-2 vaccine should have their second dose delayed, particularly if pregnant. Conclusion: To avoid further deterioration in platelet count, and avoid confusion due to the presence of different causes of thrombocytopenia and avoid complications related to thrombocytopenia during pregnancy which can affect the mode of delivery. The case is reported in line with the scare 2020 criteria Agha RA, Franchi T, Sohrabi C, Mathew G, for the SCARE Group. The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines, International Journal of Surgery 2020; 84:226–230.

4 May 2023 in Cancer Treatment and Research Communications
Verified
Journal Article
Open access
HBHaidara Bohsas
Haidara Bohsas
HAHidar Alibrahim
Hidar Alibrahim
SSSarya Swed
Sarya Swed
UKUbaid Khan
Ubaid Khan
MIMohamad Al Ibrahim
Mohamad Al Ibrahim
WHWael Hafez
Wael Hafez
This study aims to investigate the knowledge of Syrian women about breast cancer risk factors, warning signals, and barriers. Breast cancer is the most common cancer worldwide and the leading cause of cancer death among women. It develops when cells in the breast tissue grow uncontrollably, forming a tumor that can spread to other parts of the body. This survey was conducted online from September 3 to September 27, 2022, and focused on Syrian women over the age of 18. It was divided into two sections, one focusing on sociodemographic characteristics and the other on breast cancer risk factors, warning signals, and barriers. This study found that the majority of the 1305 participants had inadequate knowledge of breast cancer risk factors, warning signs, and barriers. Those with higher levels of education, such as Ph.D. students, had the highest overall scores. The sample was mostly made up of housewives, married women, and women with moderate monthly incomes. This research found that Syrian women have inadequate knowledge about breast cancer, including risk factors, warning signs, and barriers. To reduce mortality rates, increase survival rates, and improve early diagnosis, local health organizations should provide awareness courses to emphasize the importance of annual breast exams.